Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CONMED Corporation - Common Stock (NY:CNMD)

37.32 +0.68 (+1.86%)
Official Closing Price Updated: 7:00 PM EDT, May 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CONMED Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
5 Revealing Analyst Questions From CONMED’s Q1 Earnings Call
CONMED’s first quarter results were shaped by the company’s strategic exit from its gastroenterology (GI) product lines, which reduced reported sales but all... 
Via StockStory
Topics Earnings Economy
News headline image
3 Cash-Producing Stocks with Questionable Fundamentals
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
News headline image
Conmed (CNMD) Q1 2026 Earnings Transcript ↗
Conmed (CNMD) Q1 2026 Earnings Transcript 
Via The Motley Fool
CONMED Corporation (NYSE:CNMD) Beats Q1 Estimates and Raises Revenue Guidance, Shares Steady ↗
Via Chartmill
CONMED Corp (NYSE:CNMD) Posts Q4 Earnings Beat but Offers Cautious 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 1.3% year on year to $317 m... 
Via StockStory
News headline image
CONMED’s (NYSE:CNMD) Q1 CY2026 Sales Beat Estimates
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 1.3% year on year to $317 mi... 
Via StockStory
Topics Earnings
News headline image
CONMED Corporation Announces First Quarter 2026 Financial Results
From CONMED Corporation
Via Business Wire
News headline image
CONMED Earnings: What To Look For From CNMD
Medical tech company CONMED (NYSE:CNMD) will be reporting earnings this Wednesday after the bell. Here’s what you need to know. CONMED beat analysts’ revenue... 
Via StockStory
News headline image
Q4 Earnings Highs And Lows: CONMED (NYSE:CNMD) Vs The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, incl... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Small-Cap Stocks Walking a Fine Line
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026
From CONMED Corporation
Via Business Wire
News headline image
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Government Stocks
News headline image
3 Value Stocks with Open Questions
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
Topics Economy
News headline image
1 Russell 2000 Stock on Our Buy List and 2 Facing Challenges
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
Topics Economy
News headline image
3 Stocks Under $50 with Open Questions
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline... 
Via StockStory
News headline image
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
Via StockStory
Topics Economy
News headline image
1 Profitable Stock for Long-Term Investors and 2 We Ignore
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
3 Reasons CNMD is Risky and 1 Stock to Buy Instead
Over the past six months, CONMED’s shares (currently trading at $45.91) have posted a disappointing 15.7% loss, well below the S&P 500’s 7.2% gain. This was partly due to its softer quarterly results... 
Via StockStory
Topics Stocks Supply Chain
News headline image
5 Must-Read Analyst Questions From CONMED’s Q4 Earnings Call
CONMED’s fourth-quarter results were well received by the market, driven by standout performance in its orthopedics portfolio and continued progress in resolving supply chain challenges. Management... 
Via StockStory
Topics Earnings Economy
News headline image
1 Cash-Producing Stock to Target This Week and 2 We Find Risky
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2025, with sales up 7.9% year on year to $373.2 million. On the other hand, the company’s full-year revenue... 
Via StockStory
Topics Economy World Trade
News headline image
CONMED (CNMD) Q4 2025 Earnings Call Transcript ↗
CONMED (CNMD) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Economy
News headline image
CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars
Medical tech company CONMED (NYSE:CNMD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.9% year on year to $373.2 million. On the other hand, the company’s... 
Via StockStory
News headline image
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results
From CONMED Corporation
Via Business Wire
News headline image
CONMED Earnings: What To Look For From CNMD
Medical tech company CONMED (NYSE:CNMD) will be announcing earnings results this Wednesday after market close. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q3 Results: Benchmarking CONMED (NYSE:CNMD)
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including CONMED (NYSE:CNMD) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Reasons to Sell CNMD and 1 Stock to Buy Instead
Over the past six months, CONMED’s stock price fell to $43.42. Shareholders have lost 13.3% of their capital, which is disappointing considering the S&P 500 has climbed by 11.1%. This may have... 
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
What a brutal six months it’s been for CONMED. The stock has dropped 20.6% and now trades at $42.52, rattling many shareholders. This may have investors wondering how to approach the situation. 
Via StockStory
Topics Supply Chain
News headline image
CONMED Corporation Announces Chief Financial Officer Transition
From CONMED Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.